by Alzheimer's Research UKThe study, which also shows that these inequalities in England are not replicated in other parts of the UK, is published in the journalAge and Ageing.Four drug
by Alzheimer's Research UKThe study, which also shows that these inequalities in England are not replicated in other parts of the UK, is published in the journalAge and Ageing.Four drug
by Pennsylvania State UniversityCredit: Thinkstock/monkeybusinessimagesThe rate of death from Alzheimer's disease in the United States increased by more than 50 percent in the past 15 years,
by Pennsylvania State UniversityCredit: Thinkstock/monkeybusinessimagesThe rate of death from Alzheimer's disease in the United States increased by more than 50 percent in the past 15 years,
by Society of Nuclear MedicineTopographical correspondence of tau- but not amyloid-pathology with neuronal dysfunction in Alzheimer's disease. Right lateral surface of projected z-score image
by Society of Nuclear MedicineTopographical correspondence of tau- but not amyloid-pathology with neuronal dysfunction in Alzheimer's disease. Right lateral surface of projected z-score image
JANUARY 22, 2024by Brandon Chase,Massachusetts General HospitalCredit: Pixabay/CC0 Public DomainThe tau protein accumulates in abnormal shapes in the brains of individuals with Alzheimer's d
JANUARY 22, 2024by Brandon Chase,Massachusetts General HospitalCredit: Pixabay/CC0 Public DomainThe tau protein accumulates in abnormal shapes in the brains of individuals with Alzheimer's d
byUniversity of California, IrvineCredit: Pixabay/CC0 Public DomainA research team from the University of California, Irvine is the first to reveal that a molecule in the brain—ophthalmic acid—u
byUniversity of California, IrvineCredit: Pixabay/CC0 Public DomainA research team from the University of California, Irvine is the first to reveal that a molecule in the brain—ophthalmic acid—u
by Alvin Powell,Harvard UniversityHarvard University McLean researchers Bruce Cohen, left, and Kai Sonntag have found an energy dysfunction in the cells of late-onset Alzheimer's patients, a
by Alvin Powell,Harvard UniversityHarvard University McLean researchers Bruce Cohen, left, and Kai Sonntag have found an energy dysfunction in the cells of late-onset Alzheimer's patients, a
(HealthDay)—Alzheimer disease patients who initiate treatment with antipsychotic medications spend more days hospitalized than those who do not initiate antipsychotics, according to a study recently p
(HealthDay)—Alzheimer disease patients who initiate treatment with antipsychotic medications spend more days hospitalized than those who do not initiate antipsychotics, according to a study recently p